Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Recent Articles By The Author
Ignore the Escalating Trade War
The domestic economy is performing at a level unseen in almost 2 decades.
2 Core Income Stocks Investors Can Put on Auto Pilot
These boring, low-beta income plays would be a great addition to any income seeker's portfolio.
Buy Struggling Progenics and Dynavax Here
Both biotech stocks are at or near 52-week lows, but don't deserve to be.
2 Sagging Stocks Insiders Are Picking Up
Lannett Co. and Builders FirstSource have seen insiders make purchases at recent low valuations.
Names to Watch Amid Biotech's Nascent Rally
Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.
5 Small-Cap Names With Promising Profits Ahead
.We haven't seen these type of earnings gains since 2010
5 Small-Caps With Promising Profits Ahead
They are LGI Homes, Beazer Homes, Prestige Consumer Healthcare, Gulfport Energy and Cabot Oil.
Real News: Market Primed for Year-End Rally
You may have missed this, but the U.S. economy is humming.
How I See Biotechs Now
I expect deal volume to have a substantial uptick before the end of 2018 rolls around.